Arrayus Technologies Inc.

Arrayus Technologies Inc. is a Canadian medical technology company based in Burlington, Ontario, with an additional office in Toronto. The company specializes in developing a noninvasive focused ultrasound therapy platform aimed at enhancing cancer care. Founded by Dr. Kullervo Hynynen, a leader in focused ultrasound research, Arrayus utilizes proprietary technologies from Brigham and Women’s Hospital and Sunnybrook Health Sciences Centre to create advanced ultrasound arrays for therapeutic applications. The company is working on a next-generation, MR-guided focused ultrasound system that delivers multimodal energy for various clinical uses, particularly in the pelvis and abdomen. This image-guided platform enables incisionless therapy procedures, reducing the need for invasive surgery and improving patient outcomes. Arrayus is actively conducting clinical trials to validate its technology, focusing on oncological care and addressing diverse clinical needs in cancer treatment. Their solutions are designed for healthcare providers in oncology and surgery, ultimately benefiting patients seeking less invasive treatment options.

• Employees 11